Gore Bio-A Tissue Reinforcement
Payments companies reported to CMS as associated with Gore Bio-A Tissue Reinforcement. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gore Bio-A Tissue Reinforcement, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gore Bio-A Tissue Reinforcement
These are the largest totals companies reported as associated with Gore Bio-A Tissue Reinforcement. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Goldblatt | Milwaukee, WI | Surgery | $112,022.67 |
| Brant Heniford | Charlotte, NC | Surgery | $111,728.11 |
| John Linn | Glenview, IL | Surgery | $81,361.02 |
| Howard Levinson | Durham, NC | Plastic Surgery | $69,508.27 |
| John Fischer | Philadelphia, PA | Plastic Surgery | $63,328.27 |
| Rana Higgins | Milwaukee, WI | Surgery | $42,490.29 |
| Omar Kudsi | Boston, MA | Surgery | $32,792.31 |
| Leo Derosier | Tallahassee, FL | Surgery | $29,985.44 |
| Mario Leyba | Albuquerque, NM | Surgery | $28,429.19 |
| Cheguevara Afaneh | New York, NY | Surgery | $27,660.78 |
Prescribed Gore Bio-A Tissue Reinforcement?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.